In the current study, the impact of saffron and crocin extracts on NSC differentiation into OPCs was investigated. Treatment of NSCs with the studied agents significantly increased OPC differentiation, as evidenced by the high expression of early and late OPC markers, olig2 and sox10, respectively (P < 0.05). No significant difference was observed among the positive control, saffron, and crocin groups in terms of sox10 mRNA and olig2 expression. According to the findings, crocin and saffron may induce differentiation of NSCs into OPCs. To the best of authors’ knowledge, no study reported the OPC-inducing effects of saffron and crocin on NSCs differentiation.
Baharara et al., indicated that saffron extract, if used in combination with vitamin D3, can have synergistic effects on osteogenic mesenchymal stem cell differentiation in the bone marrow of rats (
38). Crocin also acts as a potent antioxidant, which decreases neuronal cell death induced by ischemic stress through increasing glutathione level and inhibiting the c-Jun N-terminal kinase (JNK) pathway (
25). Furthermore, safranal, crocin, and crocetin show neuroprotective effects by decreasing the neurotoxic molecular level in activated microglia (
35), as well as hippocampal tissue (
39).
It is shown that crocin and crocetin can inhibit nitric oxide release from microglia triggered by interferon-gamma and amyloid-beta (
35). In addition, inflammatory gene expression, endoplasmic reticulum stress in the spinal cord, and neurobehavioral deficits were ameliorated by crocin treatment in an experimental EAE model (
34). Regarding the anti-inflammatory effect of crocin, Wang et al., reported that pretreatment with crocin resulted in neuroprotective effects on traumatic brain damage, and decreased microglial activation, pro-inflammatory cytokine release, and apoptosis by activating Notch signaling pathway (
40). The present results demonstrated that crocin and aquatic extract of saffron could increase the level of Olig2 as an appropriate marker for oligodendrocyte differentiation. These differentiated cells are also potentiated to turn into mature OPCs due to increased
sox10 mRNA level in the treated group. According to some evidence,
sox10 is among
olig2 downstream targets (
22-
24). It is shown that noggin, as an antagonist of bone morphogenetic proteins (BMPs), induces the expression of
sox10 in the differentiation of retinoic acid-treated human embryonic stem (HUES) cells (
41). Literature showed that the endogenous BMP-2 signaling pathway is under the control of the commitment stage in embryonic stem cell differentiation into different lineages (
42). Moreover, to produce mature oligodendrocytes from HUES cells, Olig1/2, Sox10, and Nkx2.2, are essential (
41).
According to the results of a study, BMPs are triggered by retinoic acids in HUES cells, and noggin is necessary in the formation of mature oligodendrocytes producing MBPs. Pretreatment of such precursor cells with noggin stimulates the production of brain MBP
+ fibers in mice with MBP deficiency (
41). In another study, Lu et al., showed that treatment with noggin-modified bone marrow stromal cells and/or brain-derived neurotrophic factor could inhibit inflammation and apoptosis induced by ischemia in an ischemic stroke animal model. This might result from the upregulation of
BCL-2 and p-
GSK3β/p-Akt pathways, besides
Bax downregulation (
43).
The mentioned findings indicated the increase of sox10 expression without noggin treatment. Therefore, it can be concluded that pretreatment with crocin and saffron extracts could compensate for the noggin effect in the differentiation process. Finally, culture supplementation with crocin or saffron at certain stages (e g, incubation) might be involved in MBP+ oligodendrocyte generation in NSCs.
The present findings indicated the potential application of saffron in the inhibition of inflammation pathways, as well as treatment of neurodegenerative disorders such as MS. However, further research is required to clarify the effect of OPC pretreatment with crocin and saffron as well as the role of BMP proteins and noggin signaling before transplantation. In addition, their myelination potential in different brain regions should be evaluated in future studies. The present findings should also be analyzed in MBP-deficient mice to examine and compare the myelination potential of donor cells.
5.1. Conclusion
Treatment of NSCs with saffron and crocin significantly increased OPC differentiation, as evidenced by the high expression of early and late OPC markers, olig2 and sox10, respectively. These 2 agents could improve human-modified NSC-based therapy by considering their medical applications for remyelination or neuroprotection purposes.